Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Change in Cash (2016 - 2025)

Historic Change in Cash for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $1.4 million.

  • Healthstream's Change in Cash fell 8730.41% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year decrease of 12951.52%. This contributed to the annual value of $19.1 million for FY2024, which is 43630.93% up from last year.
  • Healthstream's Change in Cash amounted to $1.4 million in Q3 2025, which was down 8730.41% from -$25.2 million recorded in Q2 2025.
  • In the past 5 years, Healthstream's Change in Cash registered a high of $18.3 million during Q3 2023, and its lowest value of -$25.2 million during Q2 2025.
  • In the last 5 years, Healthstream's Change in Cash had a median value of $2.0 million in 2024 and averaged $893578.9.
  • Per our database at Business Quant, Healthstream's Change in Cash surged by 32922.15% in 2024 and then crashed by 30132.25% in 2025.
  • Quarter analysis of 5 years shows Healthstream's Change in Cash stood at -$8.6 million in 2021, then skyrocketed by 73.88% to -$2.2 million in 2022, then crashed by 69.65% to -$3.8 million in 2023, then skyrocketed by 152.24% to $2.0 million in 2024, then fell by 27.17% to $1.4 million in 2025.
  • Its Change in Cash stands at $1.4 million for Q3 2025, versus -$25.2 million for Q2 2025 and $17.8 million for Q1 2025.